查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
酵素替代療法市場規模 - 按酵素（Alglucosidase alfa、Agalsidase beta、Imiglucerase）、適應症（Gaucher、MPS、Pompe、SCID、Fabry）、給藥途徑、最終用戶、2023-2032 年全球預測
市場調查報告書
商品編碼
1382479

酵素替代療法市場規模 - 按酵素（Alglucosidase alfa、Agalsidase beta、Imiglucerase）、適應症（Gaucher、MPS、Pompe、SCID、Fabry）、給藥途徑、最終用戶、2023-2032 年全球預測

Enzyme Replacement Therapy Market Size - By Enzyme (Alglucosidase alfa, Agalsidase beta, Imiglucerase), Indication (Gaucher, MPS, Pompe, SCID, Fabry), Route of Administration, End-user, Global Forecast 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 197 Pages | 商品交期: 2-3個工作天內

價格

由於生物製劑和各種遺傳性疾病的標準治療方法得到更廣泛的接受，酵素替代療法市場規模預計在 2023 年至 2032 年期間CAGR將超過 7%。

包括酵素替代療法 (ERT) 在內的生物製劑作為戈謝病和法布瑞氏症等遺傳性疾病的先進標靶治療方法越來越受到重視。生物製劑的治療功效和特異性以及隨後在患者和醫療保健提供者中越來越多的採用也將促進市場成長。例如，2023年11月，武田的ADZYNMA獲得美國FDA批准，成為第一個也是唯一一個用於治療先天性血栓性血小板減少性紫斑症（cTTP）的重組ADAMTS13酶替代藥物。

酵素替代療法產業分為酵素類型、適應症、給藥途徑、最終使用者和地區。

就酵素類型而言，預計 2023 年至 2032 年伊米苷酶領域的市值CAGR將達到 8.4%。伊米苷酶已成為治療戈謝氏症的有效酵素替代療法。不斷擴大的患者群體，加上對罕見疾病的認知和診斷不斷提高，正在擴大對基於伊米苷酶的 ERT 的需求。此外，生物技術的不斷進步和持續研究將有助於該領域的成長。

根據最終用戶，輸液中心領域的 ERT 產業到 2032 年可能會實現 7.5% 的CAGR。酵素缺乏症盛行率的上升，加上酵素替代療法的接受度不斷提高，將大大增加對輸液中心服務的需求。此外，由於提供方便且受控的治療環境，患者對輸液中心的偏好不斷增加，這可能會支持該細分市場的成長。

從地區來看，由於先進的醫療基礎設施、意識的提高以及酵素缺乏症盛行率的上升，到 2032 年，歐洲酵素替代療法市場規模預計將實現 6.8% 的CAGR。此外，歐洲製藥公司和研究機構之間的合作將有助於促進 ERT 技術的進步。此外，越來越多的致力於透過創新療法改善患者治療結果將增強該地區的行業前景。例如，2023 年 5 月，歐盟委員會授予了 pegunigalsidase alfa 的行銷授權，這是一種用於治療法布瑞氏症的聚乙二醇 (PEG) 化酶。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：酵素替代療法市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 罕見遺傳疾病的發生率不斷增加
      • 對有效治療方案的需求不斷成長
      • 人們對罕見遺傳疾病的認知不斷增強
      • 生物技術與基因工程的進步
    • 產業陷阱與挑戰
      • 治療費用高
      • ERT 產品供應有限
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：酵素替代療法市場估計與預測：按酵素類型，2018-2032

  • 主要動向：依酵素類型
  • 伊米苷酶
  • 阿加糖酶BETA
  • 塔利葡萄糖酶
  • 維拉苷酶α
  • 拉羅尼酶
  • 阿葡萄糖苷酶α
  • 半乳糖酶
  • 艾杜磺酶
  • 胰酶
  • 聚乙二醇酶
  • 其他酵素類型

第 6 章：酵素替代療法市場估計與預測：按適應症分類，2018-2032 年

  • 主要動向：依指示
  • 戈謝氏症
  • 法布瑞氏症
  • 龐貝氏症
  • 漿細胞疾病
  • SCID
  • 黏多醣貯積症（MPS）
    • MPS I - Hurler、Hurler Scheie 與 Scheie
    • MPS II - 獵人
    • MPS III - 聖菲利波
    • 其他黏多醣貯積症
  • 其他適應症

第 7 章：酵素替代療法市場估計與預測：按給藥途徑，2018-2032 年

  • 主要動向：按給藥途徑
  • 注射用
  • 口服

第 8 章：酵素替代療法市場估計與預測：按最終用戶，2018-2032 年

  • 主要動向：由最終用戶
  • 醫院
  • 點滴中心
  • 其他最終用戶

第 9 章：酵素替代療法市場估計與預測：按地區，2018-2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Sanofi
  • Biomarin Pharmaceutical Inc.
  • AbbVie Inc.
  • Pfizer, Inc.
  • Alexion Pharmaceuticals Inc.
  • Allergan plc
  • Horizon Pharma Public Limited Company
  • Recordati Rare Diseases
  • Protalix Biotherapeutics
  • Amicus Therapeutics, Inc.
Product Code: 6680

Enzyme Replacement Therapy Market size is set to exhibit over 7% CAGR from 2023 to 2032, driven by the broader acceptance of biologics and standard treatments for various genetic disorders.

Biologics, including enzyme replacement therapy (ERT) are gaining prominence as advanced and targeted treatments for genetic disorders, such as Gaucher disease and Fabry disease. The therapeutic efficacy and specificity of biologics and the subsequently rising adoption amongst patients and healthcare providers will also boost the market growth. For instance, in November 2023, Takeda's ADZYNMA received clearance from the U.S. FDA as the first and only recombinant ADAMTS13 enzyme replacement medication for the treatment of congenital thrombotic thrombocytopenic purpura (cTTP).

The enzyme replacement therapy industry is segmented into enzyme type, indication, route of administration, end-user, and region.

With respect to enzyme type, the market value from imiglucerase segment is anticipated to attain 8.4% CAGR from 2023-2032. Imiglucerase has emerged as an effective enzyme replacement therapy for the treatment of Gaucher disease. The expanding patient pool coupled with the rising awareness and diagnosis of rare diseases is amplifying the demand for Imiglucerase-based ERTs. Moreover, the rising advancements in biotechnology and continuous research will contribute to the segment growth.

Based on end-user, the ERT industry from the infusion centers segment is likely to record 7.5% CAGR through 2032. The rising prevalence of enzyme deficiency disorders coupled with the increasing acceptance of enzyme replacement therapies is adding significantly to the demand for infusion center services. Additionally, the increasing patient preference for infusion centers due to the availability of convenient and controlled environment for the treatment is likely to support the segment growth.

Regionally, the Europe enzyme replacement therapy market size is slated to observe 6.8% CAGR through 2032 driven advanced healthcare infrastructure, increasing awareness, and the rising prevalence of enzyme deficiency disorders. Moreover, collaborations between pharmaceutical companies and research institutions in Europe will contribute to increasing advancements in ERT technologies. Additionally, the growing commitment to improving patient outcomes through innovative therapies will augment the regional industry outlook. For instance, in May 2023, the European Commission granted marketing authorization for pegunigalsidase alfa, the Poly (ethylene glycol) (PEG) ylated enzyme for Fabry disease.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Enzyme replacement therapy 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Enzyme type trends
    • 2.1.4 Indication trends
    • 2.1.5 Route of Administration trends
    • 2.1.6 End-user trends

Chapter 3 Enzyme Replacement Therapy Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of rare genetic disorders
      • 3.2.1.2 Rising demand for effective treatment options
      • 3.2.1.3 Growing awareness of rare genetic diseases
      • 3.2.1.4 Advancements in biotechnology and genetic engineering
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of therapy
      • 3.2.2.2 Limited availability of ERT products
  • 3.3 Growth potential analysis
    • 3.3.1 By enzyme type
    • 3.3.2 By indication
    • 3.3.3 By route of administration
    • 3.3.4 By end-user
    • 3.3.5 By region
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic dashboard, 2022

Chapter 5 Enzyme Replacement Therapy Market Estimates and Forecast, By Enzyme Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by enzyme type
  • 5.2 Imiglucerase
  • 5.3 Agalsidase beta
  • 5.4 Taliglucerase
  • 5.5 Velaglucerase alfa
  • 5.6 Laronidase
  • 5.7 Alglucosidase alfa
  • 5.8 Galsulfase
  • 5.9 Idursulfase
  • 5.10 Pancreatic enzymes
  • 5.11 Pegademase
  • 5.12 Other enzyme types

Chapter 6 Enzyme Replacement Therapy Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)

  • 6.1 Key trends, by indication
  • 6.2 Gaucher disease
  • 6.3 Fabry disease
  • 6.4 Pompe disease
  • 6.5 Plasma cell disorders
  • 6.6 SCID
  • 6.7 Mucopolysaccharidosis (MPS)
    • 6.7.1 MPS I - Hurler, Hurler Scheie and Scheie
    • 6.7.2 MPS II - Hunter
    • 6.7.3 MPS III - Sanfilippo
    • 6.7.4 Other mucopolysaccharidosis
  • 6.8 Other indications

Chapter 7 Enzyme Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Parenteral
  • 7.3 Oral

Chapter 8 Enzyme Replacement Therapy Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

  • 8.1 Key trends, by end-user
  • 8.2 Hospitals
  • 8.3 Infusion centers
  • 8.4 Other end-users

Chapter 9 Enzyme Replacement Therapy Market Estimates and Forecast, By Region, 2018-2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Sanofi
  • 10.2 Biomarin Pharmaceutical Inc.
  • 10.3 AbbVie Inc.
  • 10.4 Pfizer, Inc.
  • 10.5 Alexion Pharmaceuticals Inc.
  • 10.6 Allergan plc
  • 10.7 Horizon Pharma Public Limited Company
  • 10.8 Recordati Rare Diseases
  • 10.9 Protalix Biotherapeutics
  • 10.10 Amicus Therapeutics, Inc.

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by enzyme type (2022)
  • TABLE 3 Market revenue, by indication (2022)
  • TABLE 4 Market revenue, by route of administration (2022)
  • TABLE 5 Market revenue, by end-user (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global enzyme replacement therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global enzyme replacement therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 9 Global enzyme replacement therapy market size, by enzyme type, 2018 - 2022 (USD Million)
  • TABLE 10 Global enzyme replacement therapy market size, by enzyme type, 2018 - 2022 (USD Million)
  • TABLE 11 Global enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 12 Global enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 13 Global enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 14 Global enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 15 Global enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 16 Global enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 17 Industry impact forces
  • TABLE 18 Imiglucerase market size, 2018-2022 (USD Million)
  • TABLE 19 Imiglucerase market size, 2023-2032 (USD Million)
  • TABLE 20 Agalsidase beta market size, 2018-2022 (USD Million)
  • TABLE 21 Agalsidase beta market size, 2023-2032 (USD Million)
  • TABLE 22 Taliglucerase market size, 2018-2022 (USD Million)
  • TABLE 23 Taliglucerase market size, 2023-2032 (USD Million)
  • TABLE 24 Velaglucerase alfa market size, 2018-2022 (USD Million)
  • TABLE 25 Velaglucerase alfa market size, 2023-2032 (USD Million)
  • TABLE 26 Laronidase market size, 2018-2022 (USD Million)
  • TABLE 27 Laronidase market size, 2023-2032 (USD Million)
  • TABLE 28 Alglucosidase alfa market size, 2018-2022 (USD Million)
  • TABLE 29 Alglucosidase alfa market size, 2023-2032 (USD Million)
  • TABLE 30 Galsulfase market size, 2018-2022 (USD Million)
  • TABLE 31 Galsulfase market size, 2023-2032 (USD Million)
  • TABLE 32 Idursulfase market size, 2018-2022 (USD Million)
  • TABLE 33 Idursulfase market size, 2023-2032 (USD Million)
  • TABLE 34 Pancreatic enzymes market size, 2018-2022 (USD Million)
  • TABLE 35 Pancreatic enzymes market size, 2023-2032 (USD Million)
  • TABLE 36 Pegademase market size, 2018-2022 (USD Million)
  • TABLE 37 Pegademase market size, 2023-2032 (USD Million)
  • TABLE 38 Other enzyme types market size, 2018-2022 (USD Million)
  • TABLE 39 Other enzyme types market size, 2023-2032 (USD Million)
  • TABLE 40 Gaucher disease market size, 2018-2022 (USD Million)
  • TABLE 41 Gaucher disease market size, 2023-2032 (USD Million)
  • TABLE 42 Fabry disease market size, 2018-2022 (USD Million)
  • TABLE 43 Fabry disease market size, 2023-2032 (USD Million)
  • TABLE 44 Pompe disease market size, 2018-2022 (USD Million)
  • TABLE 45 Pompe disease market size, 2023-2032 (USD Million)
  • TABLE 46 SCID market size, 2018-2022 (USD Million)
  • TABLE 47 SCID market size, 2023-2032 (USD Million)
  • TABLE 48 Mucopolysaccharidosis (MPS) market size, 2018-2022 (USD Million)
  • TABLE 49 Mucopolysaccharidosis (MPS) market size, 2023-2032 (USD Million)
  • TABLE 50 MPS I - Hurler, Hurler Scheie and Scheie market size, 2018-2022 (USD Million)
  • TABLE 51 MPS I - Hurler, Hurler Scheie and Scheie market size, 2023-2032 (USD Million)
  • TABLE 52 MPS II - Hunter market size, 2018-2022 (USD Million)
  • TABLE 53 MPS II - Hunter market size, 2023-2032 (USD Million)
  • TABLE 54 MPS III - Sanfilippo market size, 2018-2022 (USD Million)
  • TABLE 55 MPS III - Sanfilippo market size, 2023-2032 (USD Million)
  • TABLE 56 Other mucopolysaccharidosis market size, 2018-2022 (USD Million)
  • TABLE 57 Other mucopolysaccharidosis market size, 2023-2032 (USD Million)
  • TABLE 58 Other indications market size, 2018-2022 (USD Million)
  • TABLE 59 Other indications market size, 2023-2032 (USD Million)
  • TABLE 60 Parenteral market size, 2018-2022 (USD Million)
  • TABLE 61 Parenteral market size, 2023-2032 (USD Million)
  • TABLE 62 Oral market size, 2018-2022 (USD Million)
  • TABLE 63 Oral market size, 2023-2032 (USD Million)
  • TABLE 64 Hospitals market size, 2018-2022 (USD Million)
  • TABLE 65 Hospitals market size, 2023-2032 (USD Million)
  • TABLE 66 Infusion centers market size, 2018-2022 (USD Million)
  • TABLE 67 Infusion centers market size, 2023-2032 (USD Million)
  • TABLE 68 Other end-users market size, 2018-2022 (USD Million)
  • TABLE 69 Other end-users market size, 2023-2032 (USD Million)
  • TABLE 70 North America enzyme replacement therapy Market size, by country, 2018-2022 (USD Million)
  • TABLE 71 North America enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
  • TABLE 72 North America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 73 North America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 74 North America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 75 North America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 76 North America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 77 North America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 78 North America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 79 North America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 80 North America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 81 North America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 82 U.S. enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 83 U.S. enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 84 U.S. enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 85 U.S. enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 86 U.S. enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 87 U.S. enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 88 U.S. enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 89 U.S. enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 90 U.S. enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 91 U.S. enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 92 Canada enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 93 Canada enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 94 Canada enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 95 Canada enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 96 Canada enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 97 Canada enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 98 Canada enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 99 Canada enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 100 Canada enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 101 Canada enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 102 Europe enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
  • TABLE 103 Europe enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
  • TABLE 104 Europe enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 105 Europe enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 106 Europe enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 107 Europe enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 108 Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 109 Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 110 Europe enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 111 Europe enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 112 Europe enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 113 Europe enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 114 Germany enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 115 Germany enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 116 Germany enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 117 Germany enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 118 Germany enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 119 Germany enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 120 Germany enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 121 Germany enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 122 Germany enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 123 Germany enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 124 UK enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 125 UK enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 126 UK enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 127 UK enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 128 UK enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 129 UK enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 130 UK enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 131 UK enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 132 UK enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 133 UK enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 134 France enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 135 France enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 136 France enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 137 France enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 138 France enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 139 France enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 140 France enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 141 France enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 142 France enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 143 France enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 144 Spain enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 145 Spain enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 146 Spain enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 147 Spain enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 148 Spain enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 149 Spain enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 150 Spain enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 151 Spain enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 152 Spain enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 153 Spain enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 154 Italy enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 155 Italy enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 156 Italy enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 157 Italy enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 158 Italy enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 159 Italy enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 160 Italy enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 161 Italy enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 162 Italy enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 163 Italy enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 164 Rest of Europe enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 165 Rest of Europe enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 166 Rest of Europe enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 167 Rest of Europe enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 168 Rest of Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 169 Rest of Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 170 Rest of Europe enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 171 Rest of Europe enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 172 Rest of Europe enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 173 Rest of Europe enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 174 Asia Pacific enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
  • TABLE 175 Asia Pacific enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
  • TABLE 176 Asia Pacific enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 177 Asia Pacific enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 178 Asia Pacific enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 179 Asia Pacific enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 180 Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 181 Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 182 Asia Pacific enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 183 Asia Pacific enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 184 Asia Pacific enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 185 Asia Pacific enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 186 Japan enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 187 Japan enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 188 Japan enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 189 Japan enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 190 Japan enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 191 Japan enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 192 Japan enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 193 Japan enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 194 Japan enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 195 Japan enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 196 China enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 197 China enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 198 China enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 199 China enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 200 China enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 201 China enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 202 China enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 203 China enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 204 China enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 205 China enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 206 India enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 207 India enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 208 India enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 209 India enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 210 India enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 211 India enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 212 India enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 213 India enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 214 India enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 215 India enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 216 Australia enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 217 Australia enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 218 Australia enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 219 Australia enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 220 Australia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 221 Australia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 222 Australia enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 223 Australia enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 224 Australia enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 225 Australia enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 226 South Korea enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 227 South Korea enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 228 South Korea enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 229 South Korea enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 230 South Korea enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 231 South Korea enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 232 South Korea enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 233 South Korea enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 234 South Korea enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 235 South Korea enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 236 Rest of Asia Pacific enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 237 Rest of Asia Pacific enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 238 Rest of Asia Pacific enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 239 Rest of Asia Pacific enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 240 Rest of Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 241 Rest of Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 242 Rest of Asia Pacific enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 243 Rest of Asia Pacific enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 244 Rest of Asia Pacific enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 245 Rest of Asia Pacific enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 246 Latin America enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
  • TABLE 247 Latin America enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
  • TABLE 248 Latin America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 249 Latin America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 250 Latin America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 251 Latin America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 252 Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 253 Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 254 Latin America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 255 Latin America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 256 Latin America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 257 Latin America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 258 Brazil enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 259 Brazil enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 260 Brazil enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 261 Brazil enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 262 Brazil enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 263 Brazil enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 264 Brazil enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 265 Brazil enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 266 Brazil enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 267 Brazil enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 268 Mexico enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 269 Mexico enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 270 Mexico enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 271 Mexico enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 272 Mexico enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 273 Mexico enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 274 Mexico enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 275 Mexico enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 276 Mexico enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 277 Mexico enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 278 Rest of Latin America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 279 Rest of Latin America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 280 Rest of Latin America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 281 Rest of Latin America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 282 Rest of Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 283 Rest of Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 284 Rest of Latin America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 285 Rest of Latin America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 286 Rest of Latin America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 287 Rest of Latin America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 288 Middle East & Africa enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
  • TABLE 289 Middle East & Africa enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
  • TABLE 290 Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 291 Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 292 Middle East & Africa enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 293 Middle East & Africa enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 294 Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 295 Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 296 Middle East & Africa enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 297 Middle East & Africa enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 298 Middle East & Africa enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 299 Middle East & Africa enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 300 South Africa enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 301 South Africa enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 302 South Africa enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 303 South Africa enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 304 South Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 305 South Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 306 South Africa enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 307 South Africa enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 308 South Africa enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 309 South Africa enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 310 Saudi Arabia enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 311 Saudi Arabia enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 312 Saudi Arabia enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 313 Saudi Arabia enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 314 Saudi Arabia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 315 Saudi Arabia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 316 Saudi Arabia enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 317 Saudi Arabia enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 318 Saudi Arabia enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 319 Saudi Arabia enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
  • TABLE 320 Rest of Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
  • TABLE 321 Rest of Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
  • TABLE 322 Rest of Middle East & Africa enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
  • TABLE 323 Rest of Middle East & Africa enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
  • TABLE 324 Rest of Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
  • TABLE 325 Rest of Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
  • TABLE 326 Rest of Middle East & Africa enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 327 Rest of Middle East & Africa enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 328 Rest of Middle East & Africa enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
  • TABLE 329 Rest of Middle East & Africa enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Enzyme replacement therapy market 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by enzyme type
  • FIG 8 Growth potential analysis, by indication
  • FIG 9 Growth potential analysis, by route of administration
  • FIG 10 Growth potential analysis, by end-user
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Global company market share analysis, 2022
  • FIG 15 Competitive positioning matrix, 2022
  • FIG 16 Strategic dashboard, 2022